Evidence map›Paper›PMID 38159850›Full record

SynthesisThe Journal of biological chemistry2024

Tools for investigating O-GlcNAc in signaling and other fundamental biological pathways.

Zachary M Nelson, Garry D Leonard, Charlie Fehl

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. O-GlcNAc informatics: advances and trends.Analytical and bioanalytical chemistry · 2025
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zachary M NelsonDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Garry D LeonardDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA.
Charlie FehlDepartment of Chemistry, Wayne State University, Detroit, Michigan, USA. Electronic address: charlie.fehl@wayne.edu.
Wayne State University · US

Funding

THE ROLE OF CNS INSULIN AS A MODULATOR OF DIABETIC COMPLICATIONSR25GM058905 · NIGMS · WAYNE STATE UNIVERSITY · PI CHOW, CHRISTINE S, DUNBAR, JOSEPH C · 1999 to 2020
$14.4M
Spatiotemporal tools to interrogate O-GlcNAc functions in metabolic signaling and diseaseR35GM142637 · NIGMS · WAYNE STATE UNIVERSITY · PI Charlie Fehl · 2021 to 2026
$2.6M
Training Modules at Wayne State University to Promote Safe and Inclusive EnvironmentsT32GM139807 · NIGMS · WAYNE STATE UNIVERSITY · PI BRYANT-FRIEDRICH, AMANDA C, CHOW, CHRISTINE S · 2021 to 2025
$2.6M
NIGMS NIH HHS R25 GM058905NIGMS NIH HHS R35 GM142637NIGMS NIH HHS T32 GM139807
6 · The paper itself

Abstract

Cells continuously fine-tune signaling pathway proteins to match nutrient and stress levels in their local environment by modifying intracellular proteins with O-linked N-acetylglucosamine (O-GlcNAc) sugars, an essential process for cell survival and growth. The small size of these monosaccharide modifications poses a challenge for functional determination, but the chemistry and biology communities have together created a collection of precision tools to study these dynamic sugars. This review presents the major themes by which O-GlcNAc influences signaling pathway proteins, including G-protein coupled receptors, growth factor signaling, mitogen-activated protein kinase (MAPK) pathways, lipid sensing, and cytokine signaling pathways. Along the way, we describe in detail key chemical biology tools that have been developed and applied to determine specific O-GlcNAc roles in these pathways. These tools include metabolic labeling, O-GlcNAc-enhancing RNA aptamers, fluorescent biosensors, proximity labeling tools, nanobody targeting tools, O-GlcNAc cycling inhibitors, light-activated systems, chemoenzymatic labeling, and nutrient reporter assays. An emergent feature of this signaling pathway meta-analysis is the intricate interplay between O-GlcNAc modifications across different signaling systems, underscoring the importance of O-GlcNAc in regulating cellular processes. We highlight the significance of O-GlcNAc in signaling and the role of chemical and biochemical tools in unraveling distinct glycobiological regulatory mechanisms. Collectively, our field has determined effective strategies to probe O-GlcNAc roles in biology. At the same time, this survey of what we do not yet know presents a clear roadmap for the field to use these powerful chemical tools to explore cross-pathway O-GlcNAc interactions in signaling and other major biological pathways.

Indexed as

AcetylglucosamineChemistry Techniques, AnalyticalSignal TransductionBiochemistryBiotechnologyReceptors, G-Protein-CoupledAcetylglucosamineReceptors, G-Protein-Coupledchemical biology toolscytokinesfunctional glycobiologyGPCRMAPKnutrient sensingO-GlcNAcRTKsignaling pathways

Identifiers

PMID38159850
PMCPMC10831167
OpenAlexW4390369240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.